Roche Holding

Roche Holding, parent of Swiss Drug company Hoffmann-LaRoche bought Syntes for 5.3 billion. 

In Europe, as Table 1.2 illustrates, the German and Swiss leaders were the Rhine Valley chemical companies, whose evolution has been sketched above. The British companies became significant competitors after World War II, but France s Rhone-Poulenc failed to become a factor in world markets. The most successful European pharmaceutical company of all in terms of revenues and profits was F. Hoffmann-La Roche (now Roche Holding), established in 1894 in Basel, Switzerland, the headquarters site of the three Swiss chemical companies listed in Table 1.1. 

Roche Holding Limited DNA tests, diabetes monitoring supphes, and... 

The major active metabolite of etretinate, is a second generation monoaromatic retinoid for use in the treatment of severe psoriasis and other dermatoses.( O) It is currently marketed by Roche Holding... 

---